- Home
- JBLU vs AMLX Comparison
JBLU vs AMLX Comparison
Compare JBLU & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBLU
- AMLX
- Stock Information
- Founded
- JBLU 1998
- AMLX 2014
- Country
- JBLU United States
- AMLX United States
- Employees
- JBLU N/A
- AMLX N/A
- Industry
- JBLU Air Freight/Delivery Services
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- JBLU Consumer Discretionary
- AMLX Health Care
- Exchange
- JBLU Nasdaq
- AMLX Nasdaq
- Market Cap
- JBLU 1.5B
- AMLX 1.3B
- IPO Year
- JBLU N/A
- AMLX 2022
- Fundamental
- Price
- JBLU $4.57
- AMLX $14.97
- Analyst Decision
- JBLU Sell
- AMLX Strong Buy
- Analyst Count
- JBLU 8
- AMLX 7
- Target Price
- JBLU $5.04
- AMLX $17.43
- AVG Volume (30 Days)
- JBLU 17.6M
- AMLX 1.5M
- Earning Date
- JBLU 10-28-2025
- AMLX 11-06-2025
- Dividend Yield
- JBLU N/A
- AMLX N/A
- EPS Growth
- JBLU N/A
- AMLX N/A
- EPS
- JBLU N/A
- AMLX N/A
- Revenue
- JBLU $9,095,000,000.00
- AMLX N/A
- Revenue This Year
- JBLU N/A
- AMLX N/A
- Revenue Next Year
- JBLU $8.00
- AMLX N/A
- P/E Ratio
- JBLU N/A
- AMLX N/A
- Revenue Growth
- JBLU N/A
- AMLX N/A
- 52 Week Low
- JBLU $3.34
- AMLX $2.60
- 52 Week High
- JBLU $8.31
- AMLX $16.96
- Technical
- Relative Strength Index (RSI)
- JBLU 58.13
- AMLX 61.79
- Support Level
- JBLU $4.00
- AMLX $14.48
- Resistance Level
- JBLU $4.29
- AMLX $15.39
- Average True Range (ATR)
- JBLU 0.19
- AMLX 0.95
- MACD
- JBLU 0.05
- AMLX 0.21
- Stochastic Oscillator
- JBLU 97.59
- AMLX 88.34
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.